Jorge Sepulcre, D.M.Sc., M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
tau Proteins | 26 | 2024 | 2095 | 3.780 |
Why?
|
Nerve Net | 29 | 2024 | 2288 | 2.770 |
Why?
|
Alzheimer Disease | 35 | 2024 | 8592 | 2.390 |
Why?
|
Neural Pathways | 27 | 2022 | 3057 | 2.340 |
Why?
|
Brain | 64 | 2024 | 27103 | 2.220 |
Why?
|
Brain Mapping | 37 | 2024 | 6626 | 1.860 |
Why?
|
Positron-Emission Tomography | 34 | 2024 | 6478 | 1.850 |
Why?
|
Cerebral Cortex | 25 | 2024 | 5776 | 1.850 |
Why?
|
Amyloid beta-Peptides | 21 | 2024 | 3836 | 1.800 |
Why?
|
Aging | 12 | 2024 | 8704 | 1.340 |
Why?
|
Multiple Sclerosis | 21 | 2017 | 3222 | 1.170 |
Why?
|
Magnetic Resonance Imaging | 69 | 2024 | 36430 | 1.060 |
Why?
|
Models, Neurological | 7 | 2021 | 1767 | 1.030 |
Why?
|
Visual Pathways | 3 | 2016 | 551 | 0.980 |
Why?
|
Sensation | 4 | 2021 | 337 | 0.970 |
Why?
|
Olfactory Perception | 1 | 2024 | 65 | 0.900 |
Why?
|
Amyloid | 4 | 2024 | 840 | 0.870 |
Why?
|
Visual Cortex | 4 | 2020 | 1107 | 0.830 |
Why?
|
Motor Cortex | 4 | 2020 | 1006 | 0.820 |
Why?
|
Semantics | 5 | 2020 | 601 | 0.810 |
Why?
|
Executive Function | 5 | 2021 | 1389 | 0.780 |
Why?
|
Somatosensory Cortex | 2 | 2017 | 512 | 0.770 |
Why?
|
Apolipoprotein E4 | 3 | 2022 | 708 | 0.760 |
Why?
|
Cognition | 10 | 2024 | 6987 | 0.740 |
Why?
|
Attention | 5 | 2019 | 2395 | 0.690 |
Why?
|
Stuttering | 1 | 2019 | 25 | 0.680 |
Why?
|
Verbal Behavior | 3 | 2010 | 335 | 0.640 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 7 | 2011 | 555 | 0.630 |
Why?
|
Education | 1 | 2021 | 536 | 0.620 |
Why?
|
Image Processing, Computer-Assisted | 25 | 2021 | 8997 | 0.620 |
Why?
|
Quantitative Trait, Heritable | 1 | 2021 | 542 | 0.620 |
Why?
|
Amyloidosis | 2 | 2022 | 817 | 0.600 |
Why?
|
T-Box Domain Proteins | 1 | 2020 | 468 | 0.570 |
Why?
|
Neurofilament Proteins | 1 | 2019 | 336 | 0.570 |
Why?
|
Atrophy | 12 | 2023 | 1632 | 0.570 |
Why?
|
Aniline Compounds | 12 | 2019 | 1069 | 0.540 |
Why?
|
Eye Movements | 1 | 2019 | 511 | 0.530 |
Why?
|
Calcium Channels | 1 | 2020 | 620 | 0.530 |
Why?
|
Myotonic Dystrophy | 3 | 2021 | 78 | 0.520 |
Why?
|
Neuronal Plasticity | 4 | 2021 | 1435 | 0.520 |
Why?
|
Speech | 2 | 2024 | 554 | 0.480 |
Why?
|
Visual Perception | 2 | 2020 | 1385 | 0.470 |
Why?
|
Nonlinear Dynamics | 1 | 2016 | 493 | 0.460 |
Why?
|
Lysosomes | 1 | 2019 | 921 | 0.460 |
Why?
|
Thiazoles | 11 | 2019 | 1516 | 0.450 |
Why?
|
Efferent Pathways | 1 | 2014 | 165 | 0.440 |
Why?
|
Adaptation, Physiological | 2 | 2018 | 1301 | 0.440 |
Why?
|
Blindness | 1 | 2017 | 584 | 0.430 |
Why?
|
Male | 96 | 2024 | 360621 | 0.420 |
Why?
|
Evolution, Molecular | 1 | 2021 | 1888 | 0.420 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 5 | 2022 | 3704 | 0.410 |
Why?
|
Humans | 128 | 2024 | 761326 | 0.410 |
Why?
|
Neuropsychological Tests | 16 | 2020 | 7045 | 0.400 |
Why?
|
Female | 93 | 2024 | 392485 | 0.380 |
Why?
|
Conversion Disorder | 3 | 2020 | 202 | 0.380 |
Why?
|
Mental Processes | 1 | 2012 | 244 | 0.370 |
Why?
|
Learning | 2 | 2020 | 1740 | 0.370 |
Why?
|
Individuality | 3 | 2018 | 300 | 0.360 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 3 | 2009 | 254 | 0.360 |
Why?
|
Prefrontal Cortex | 2 | 2019 | 2219 | 0.340 |
Why?
|
HLA-DR2 Antigen | 1 | 2008 | 47 | 0.310 |
Why?
|
Cognition Disorders | 9 | 2017 | 3979 | 0.310 |
Why?
|
Adult | 59 | 2024 | 221122 | 0.300 |
Why?
|
Neurofibrillary Tangles | 2 | 2022 | 457 | 0.300 |
Why?
|
Carbolines | 4 | 2019 | 294 | 0.300 |
Why?
|
Disease Progression | 11 | 2021 | 13500 | 0.300 |
Why?
|
Parietal Lobe | 2 | 2013 | 851 | 0.290 |
Why?
|
Parkinson Disease | 1 | 2022 | 2876 | 0.290 |
Why?
|
Verbal Learning | 2 | 2017 | 463 | 0.290 |
Why?
|
Retinal Vein | 1 | 2007 | 47 | 0.290 |
Why?
|
Obsessive-Compulsive Disorder | 4 | 2020 | 1491 | 0.280 |
Why?
|
Aged | 35 | 2024 | 169179 | 0.280 |
Why?
|
Apolipoproteins E | 2 | 2022 | 1444 | 0.270 |
Why?
|
Memory | 7 | 2020 | 2187 | 0.270 |
Why?
|
Mental Recall | 2 | 2010 | 1214 | 0.270 |
Why?
|
Frontal Lobe | 2 | 2013 | 1420 | 0.270 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2009 | 952 | 0.270 |
Why?
|
Young Adult | 25 | 2024 | 59196 | 0.260 |
Why?
|
Aged, 80 and over | 21 | 2024 | 58946 | 0.260 |
Why?
|
Oxygen | 7 | 2017 | 4227 | 0.250 |
Why?
|
Locus Coeruleus | 2 | 2024 | 230 | 0.250 |
Why?
|
Proteins | 1 | 2020 | 6034 | 0.240 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 4414 | 0.230 |
Why?
|
Amyloidogenic Proteins | 2 | 2022 | 151 | 0.230 |
Why?
|
Fractals | 3 | 2017 | 128 | 0.230 |
Why?
|
Fluorine Radioisotopes | 2 | 2017 | 418 | 0.230 |
Why?
|
Memory, Short-Term | 2 | 2017 | 982 | 0.230 |
Why?
|
Memory Disorders | 5 | 2023 | 1198 | 0.220 |
Why?
|
Olfactory Pathways | 1 | 2024 | 132 | 0.210 |
Why?
|
Nervous System Diseases | 3 | 2018 | 1665 | 0.210 |
Why?
|
Smell | 1 | 2024 | 259 | 0.200 |
Why?
|
Combat Disorders | 1 | 2024 | 301 | 0.200 |
Why?
|
Fatigue | 1 | 2008 | 1551 | 0.190 |
Why?
|
Temporal Lobe | 3 | 2024 | 1695 | 0.190 |
Why?
|
Essential Tremor | 1 | 2023 | 157 | 0.180 |
Why?
|
Computational Biology | 2 | 2010 | 3512 | 0.180 |
Why?
|
Retinal Diseases | 1 | 2007 | 704 | 0.180 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11900 | 0.180 |
Why?
|
Benzothiazoles | 3 | 2017 | 247 | 0.180 |
Why?
|
Vision Disorders | 2 | 2024 | 1088 | 0.180 |
Why?
|
Transferases (Other Substituted Phosphate Groups) | 1 | 2019 | 36 | 0.170 |
Why?
|
Dystrophin | 1 | 2021 | 283 | 0.170 |
Why?
|
Synaptic Vesicles | 1 | 2021 | 190 | 0.170 |
Why?
|
Retina | 2 | 2008 | 2656 | 0.170 |
Why?
|
Investments | 1 | 2021 | 147 | 0.170 |
Why?
|
Epilepsies, Myoclonic | 1 | 2020 | 85 | 0.160 |
Why?
|
Middle Aged | 38 | 2024 | 220774 | 0.160 |
Why?
|
Prader-Willi Syndrome | 1 | 2020 | 78 | 0.160 |
Why?
|
Cross-Sectional Studies | 7 | 2022 | 26108 | 0.160 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2021 | 415 | 0.160 |
Why?
|
Malformations of Cortical Development | 1 | 2020 | 176 | 0.160 |
Why?
|
Long-Term Synaptic Depression | 1 | 2018 | 60 | 0.150 |
Why?
|
Atlases as Topic | 1 | 2019 | 248 | 0.150 |
Why?
|
Disability Evaluation | 6 | 2017 | 1836 | 0.150 |
Why?
|
Endophenotypes | 1 | 2020 | 255 | 0.150 |
Why?
|
Cocaine-Related Disorders | 1 | 2021 | 461 | 0.150 |
Why?
|
Judgment | 1 | 2020 | 273 | 0.150 |
Why?
|
Models, Biological | 4 | 2018 | 9468 | 0.140 |
Why?
|
Interferon-gamma | 1 | 2005 | 3159 | 0.140 |
Why?
|
Gyrus Cinguli | 3 | 2019 | 1115 | 0.140 |
Why?
|
Cluster Analysis | 4 | 2015 | 2712 | 0.140 |
Why?
|
Long-Term Potentiation | 1 | 2018 | 293 | 0.140 |
Why?
|
Longitudinal Studies | 8 | 2021 | 14597 | 0.140 |
Why?
|
Meta-Analysis as Topic | 2 | 2019 | 1376 | 0.140 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2018 | 3356 | 0.140 |
Why?
|
Neostriatum | 1 | 2017 | 246 | 0.130 |
Why?
|
Universities | 1 | 2021 | 994 | 0.130 |
Why?
|
Disabled Persons | 1 | 2006 | 1225 | 0.130 |
Why?
|
Tauopathies | 1 | 2019 | 320 | 0.130 |
Why?
|
Dissociative Disorders | 1 | 2018 | 234 | 0.130 |
Why?
|
Cohort Studies | 9 | 2020 | 41440 | 0.130 |
Why?
|
Biological Evolution | 1 | 2021 | 1073 | 0.130 |
Why?
|
Corpus Striatum | 2 | 2020 | 1235 | 0.130 |
Why?
|
Optic Neuritis | 2 | 2008 | 174 | 0.130 |
Why?
|
Organ Size | 2 | 2017 | 2252 | 0.130 |
Why?
|
Psychophysiologic Disorders | 1 | 2017 | 221 | 0.120 |
Why?
|
Motor Skills | 1 | 2018 | 520 | 0.120 |
Why?
|
Limbic System | 1 | 2017 | 419 | 0.120 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9414 | 0.120 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1025 | 0.120 |
Why?
|
Psychomotor Performance | 2 | 2020 | 1879 | 0.120 |
Why?
|
Functional Laterality | 2 | 2012 | 2256 | 0.120 |
Why?
|
Movement Disorders | 1 | 2018 | 459 | 0.110 |
Why?
|
Optic Nerve | 2 | 2008 | 572 | 0.110 |
Why?
|
Dopamine | 1 | 2021 | 1605 | 0.110 |
Why?
|
Amygdala | 2 | 2019 | 1353 | 0.110 |
Why?
|
Educational Status | 3 | 2017 | 2520 | 0.110 |
Why?
|
Diffusion Tensor Imaging | 2 | 2021 | 2399 | 0.110 |
Why?
|
Reaction Time | 1 | 2019 | 2080 | 0.110 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2005 | 4371 | 0.110 |
Why?
|
Photic Stimulation | 2 | 2016 | 1985 | 0.100 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2024 | 4579 | 0.100 |
Why?
|
Carbon Isotopes | 1 | 2013 | 458 | 0.100 |
Why?
|
Body Dysmorphic Disorders | 1 | 2016 | 243 | 0.100 |
Why?
|
Adolescent | 15 | 2024 | 88305 | 0.100 |
Why?
|
Linear Models | 3 | 2012 | 5871 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2005 | 4576 | 0.100 |
Why?
|
Regression Analysis | 3 | 2018 | 6341 | 0.100 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2007 | 822 | 0.090 |
Why?
|
Neurodegenerative Diseases | 1 | 2020 | 1086 | 0.090 |
Why?
|
Alleles | 1 | 2022 | 6909 | 0.090 |
Why?
|
Cerebellum | 1 | 2018 | 1500 | 0.090 |
Why?
|
Athletes | 1 | 2018 | 1136 | 0.090 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2017 | 2009 | 0.090 |
Why?
|
Psycholinguistics | 1 | 2010 | 79 | 0.090 |
Why?
|
Statistics as Topic | 3 | 2017 | 2358 | 0.090 |
Why?
|
Radiopharmaceuticals | 2 | 2017 | 2650 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1900 | 0.090 |
Why?
|
Veterans | 1 | 2024 | 2647 | 0.080 |
Why?
|
Concept Formation | 1 | 2010 | 161 | 0.080 |
Why?
|
Retrograde Degeneration | 1 | 2009 | 8 | 0.080 |
Why?
|
Case-Control Studies | 8 | 2019 | 22124 | 0.080 |
Why?
|
Psychotic Disorders | 1 | 2024 | 3223 | 0.080 |
Why?
|
Feedback, Physiological | 1 | 2011 | 476 | 0.080 |
Why?
|
Follow-Up Studies | 8 | 2020 | 39108 | 0.080 |
Why?
|
Glutamate Plasma Membrane Transport Proteins | 1 | 2008 | 11 | 0.080 |
Why?
|
Child Abuse | 1 | 2017 | 1075 | 0.080 |
Why?
|
Memantine | 1 | 2008 | 108 | 0.070 |
Why?
|
Peptide Fragments | 2 | 2017 | 5114 | 0.070 |
Why?
|
Geniculate Bodies | 1 | 2009 | 160 | 0.070 |
Why?
|
Child | 8 | 2022 | 80156 | 0.070 |
Why?
|
Perception | 1 | 2014 | 1197 | 0.070 |
Why?
|
Phlebitis | 1 | 2007 | 35 | 0.070 |
Why?
|
Decision Making | 1 | 2021 | 3929 | 0.070 |
Why?
|
Adaptation, Psychological | 1 | 2018 | 2630 | 0.070 |
Why?
|
Epilepsies, Partial | 1 | 2011 | 431 | 0.070 |
Why?
|
Thionucleosides | 1 | 2006 | 13 | 0.070 |
Why?
|
Herpesvirus 6, Human | 1 | 2007 | 96 | 0.070 |
Why?
|
Nerve Degeneration | 1 | 2011 | 748 | 0.070 |
Why?
|
Pattern Recognition, Automated | 1 | 2013 | 997 | 0.070 |
Why?
|
Neocortex | 1 | 2010 | 417 | 0.070 |
Why?
|
Vision, Ocular | 1 | 2009 | 455 | 0.070 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2008 | 448 | 0.070 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2011 | 710 | 0.070 |
Why?
|
Predictive Value of Tests | 4 | 2013 | 15262 | 0.060 |
Why?
|
Evoked Potentials, Auditory | 1 | 2009 | 530 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 2 | 2017 | 4063 | 0.060 |
Why?
|
Prognosis | 4 | 2021 | 29588 | 0.060 |
Why?
|
Epilepsy | 1 | 2020 | 3290 | 0.060 |
Why?
|
Nerve Fibers | 1 | 2008 | 708 | 0.060 |
Why?
|
Reference Values | 2 | 2015 | 4921 | 0.060 |
Why?
|
Prospective Studies | 6 | 2023 | 54405 | 0.060 |
Why?
|
Health Status | 1 | 2017 | 4075 | 0.060 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2019 | 6019 | 0.050 |
Why?
|
Hippocampus | 2 | 2018 | 3763 | 0.050 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2004 | 113 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 1 | 2011 | 1805 | 0.050 |
Why?
|
Calcium-Binding Proteins | 1 | 2007 | 1069 | 0.050 |
Why?
|
Tremor | 1 | 2023 | 191 | 0.050 |
Why?
|
Anxiety | 1 | 2017 | 4571 | 0.050 |
Why?
|
Schizophrenia | 1 | 2021 | 6937 | 0.050 |
Why?
|
Interleukin-10 | 1 | 2008 | 1175 | 0.050 |
Why?
|
Glutamic Acid | 1 | 2008 | 1176 | 0.050 |
Why?
|
Twins, Monozygotic | 1 | 2024 | 470 | 0.050 |
Why?
|
Early Diagnosis | 1 | 2007 | 1184 | 0.050 |
Why?
|
Basal Ganglia | 2 | 2016 | 554 | 0.050 |
Why?
|
Herpesvirus 4, Human | 1 | 2007 | 1079 | 0.050 |
Why?
|
Retinal Ganglion Cells | 1 | 2007 | 811 | 0.050 |
Why?
|
Axons | 1 | 2009 | 1674 | 0.050 |
Why?
|
Lymphocyte Activation | 2 | 2011 | 5491 | 0.050 |
Why?
|
Language | 1 | 2009 | 1539 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2021 | 421 | 0.040 |
Why?
|
Neurons | 1 | 2019 | 9458 | 0.040 |
Why?
|
Animals | 7 | 2023 | 168388 | 0.040 |
Why?
|
Carbon Radioisotopes | 1 | 2020 | 562 | 0.040 |
Why?
|
Dermatoglyphics | 1 | 2018 | 20 | 0.040 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2019 | 247 | 0.040 |
Why?
|
Presenilin-1 | 1 | 2022 | 659 | 0.040 |
Why?
|
Putamen | 1 | 2019 | 292 | 0.040 |
Why?
|
Markov Chains | 1 | 2021 | 965 | 0.040 |
Why?
|
Severity of Illness Index | 4 | 2019 | 15835 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4286 | 0.040 |
Why?
|
Thiones | 1 | 2017 | 46 | 0.040 |
Why?
|
Systems Integration | 1 | 2019 | 426 | 0.040 |
Why?
|
Tomography, Optical Coherence | 2 | 2008 | 2915 | 0.040 |
Why?
|
Thalamus | 1 | 2023 | 1044 | 0.040 |
Why?
|
Immunologic Factors | 1 | 2006 | 1589 | 0.040 |
Why?
|
Palmitates | 1 | 2017 | 70 | 0.040 |
Why?
|
Genotype | 2 | 2008 | 12982 | 0.030 |
Why?
|
Ethylene Glycols | 1 | 2017 | 190 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2007 | 3155 | 0.030 |
Why?
|
Anisotropy | 1 | 2019 | 1283 | 0.030 |
Why?
|
Probability | 1 | 2021 | 2478 | 0.030 |
Why?
|
Speech Disorders | 1 | 2017 | 180 | 0.030 |
Why?
|
Membrane Potentials | 1 | 2019 | 1089 | 0.030 |
Why?
|
Dominance, Cerebral | 1 | 2017 | 623 | 0.030 |
Why?
|
Age Factors | 2 | 2017 | 18401 | 0.030 |
Why?
|
Heterozygote | 1 | 2022 | 2803 | 0.030 |
Why?
|
Language Tests | 1 | 2015 | 190 | 0.030 |
Why?
|
Fourier Analysis | 1 | 2015 | 441 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2008 | 3075 | 0.030 |
Why?
|
Central Nervous System | 1 | 2021 | 1337 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2008 | 10191 | 0.030 |
Why?
|
Electroencephalography | 1 | 2009 | 6224 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2023 | 3768 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2024 | 2790 | 0.030 |
Why?
|
Prevalence | 2 | 2008 | 15719 | 0.030 |
Why?
|
Auditory Perception | 1 | 2017 | 583 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2018 | 20092 | 0.020 |
Why?
|
Life Change Events | 1 | 2017 | 952 | 0.020 |
Why?
|
Bayes Theorem | 2 | 2011 | 2329 | 0.020 |
Why?
|
Algorithms | 3 | 2018 | 14025 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2017 | 1988 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2007 | 7852 | 0.020 |
Why?
|
Phenotype | 1 | 2008 | 16603 | 0.020 |
Why?
|
Neural Conduction | 1 | 2011 | 441 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4567 | 0.020 |
Why?
|
Affect | 1 | 2017 | 1485 | 0.020 |
Why?
|
Rats | 2 | 2021 | 23729 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2013 | 2265 | 0.020 |
Why?
|
Imagination | 1 | 2010 | 226 | 0.020 |
Why?
|
Acoustic Stimulation | 1 | 2013 | 1235 | 0.020 |
Why?
|
Psychometrics | 1 | 2018 | 3064 | 0.020 |
Why?
|
Evoked Potentials, Motor | 1 | 2011 | 464 | 0.020 |
Why?
|
Receptors, Interleukin-10 | 1 | 2008 | 50 | 0.020 |
Why?
|
Systems Biology | 1 | 2011 | 481 | 0.020 |
Why?
|
Peripheral Nerves | 1 | 2011 | 479 | 0.020 |
Why?
|
Ferrous Compounds | 1 | 1987 | 41 | 0.020 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2008 | 89 | 0.020 |
Why?
|
Gene Expression | 1 | 2020 | 7582 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2009 | 999 | 0.020 |
Why?
|
Phytohemagglutinins | 1 | 2006 | 168 | 0.020 |
Why?
|
Brain Concussion | 1 | 2018 | 1404 | 0.020 |
Why?
|
Magnetoencephalography | 1 | 2011 | 636 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2008 | 868 | 0.020 |
Why?
|
Contrast Media | 1 | 2019 | 5310 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18234 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2013 | 2332 | 0.020 |
Why?
|
Models, Psychological | 1 | 2010 | 828 | 0.020 |
Why?
|
Computer Simulation | 2 | 2011 | 6236 | 0.020 |
Why?
|
Iatrogenic Disease | 1 | 2008 | 539 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2008 | 10764 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2015 | 2691 | 0.020 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2006 | 512 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2006 | 1158 | 0.010 |
Why?
|
Retinal Degeneration | 1 | 2008 | 413 | 0.010 |
Why?
|
Placebos | 1 | 2008 | 1667 | 0.010 |
Why?
|
Immunotherapy | 2 | 2011 | 4649 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2015 | 3577 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2008 | 2075 | 0.010 |
Why?
|
Treatment Failure | 1 | 2008 | 2642 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2008 | 1474 | 0.010 |
Why?
|
Image Enhancement | 1 | 2013 | 2884 | 0.010 |
Why?
|
Drug Interactions | 1 | 2006 | 1415 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 80575 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6231 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2013 | 2897 | 0.010 |
Why?
|
Gene Frequency | 1 | 2008 | 3639 | 0.010 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2006 | 1110 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2006 | 2853 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4850 | 0.010 |
Why?
|
Down-Regulation | 1 | 2008 | 2913 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3806 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1650 | 0.010 |
Why?
|
Time Factors | 2 | 2013 | 39974 | 0.010 |
Why?
|
Age of Onset | 1 | 2006 | 3303 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2008 | 2300 | 0.010 |
Why?
|
Monocytes | 1 | 2008 | 2573 | 0.010 |
Why?
|
Cerebral Angiography | 1 | 2004 | 1281 | 0.010 |
Why?
|
Lymphocytes | 1 | 2006 | 2610 | 0.010 |
Why?
|
Iron | 1 | 1987 | 1792 | 0.010 |
Why?
|
Emotions | 1 | 2010 | 2738 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14665 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2007 | 5866 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2023 | 64645 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17872 | 0.010 |
Why?
|
Protein Binding | 1 | 2008 | 9351 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10551 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2008 | 12329 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 18962 | 0.010 |
Why?
|
Macrophages | 1 | 2006 | 5768 | 0.010 |
Why?
|
Cytokines | 1 | 2006 | 7390 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2006 | 12787 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 22154 | 0.010 |
Why?
|
Quality of Life | 1 | 2008 | 13355 | 0.000 |
Why?
|
France | 1 | 1987 | 498 | 0.000 |
Why?
|
Signal Transduction | 1 | 2008 | 23427 | 0.000 |
Why?
|
Mice | 1 | 2007 | 81474 | 0.000 |
Why?
|
Administration, Oral | 1 | 1987 | 4013 | 0.000 |
Why?
|
Child, Preschool | 1 | 1987 | 42251 | 0.000 |
Why?
|